Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NEXAFED Sinus Pressure+Pain
- Development stage
- Phase 3
- Lead developer
- Acura Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
NEXAFED Sinus Pressure+Pain is an oral immediate-release combination small-molecule cold and sinus product developed by Acura using its IMPEDE meth-resistant formulation technology. The product combines pseudoephedrine and acetaminophen for temporary relief of sinus congestion and pressure associated with colds or allergies, and pain or fever associated with colds and sinus headache. Acura's IMPEDE polymer matrix is intended to impede extraction and chemical conversion of pseudoephedrine into methamphetamine while preserving oral decongestant activity; the brand has been associated with commercialization through MainPointe for marketed NEXAFED products, while Acura's pipeline also lists NEXAFED Sinus Pressure+Pain as a line extension for sinus pressure and pain.
- Brand names
- NEXAFED Sinus Pressure+Pain
- Other names
- NEXAFED Sinus Pressure + Pain
02
Targets
AR (Adrenergic receptors)COX
Beyond the preview
Go deeper on NEXAFED Sinus Pressure+Pain.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NEXAFED Sinus Pressure+Pain.